Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Survey on the current use of FMT in pediatric patients receiving hematopoietic stem cell transplantation and cellular therapies

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Riccardo Masetti

HSCT in patients with GLIS2+ AML study

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Second allogeneic HSCT for relapsed pediatric ALL: a collaborative study on behalf of the Brazilian PDWP (SBTMO) and the European EBMT PDWP (J. Silva, C. Bonfim)

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Julia Silva, Carmen Bonfim

Outcomes of children with AML relapse within 6 months post HSCT (C. Horgan/R. Wynn)

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Claire Horgan / Rob Wynn

Allogeneic vs autologous HSCT in B-cell NHL (D. Przystupski)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Real-world data on the outcome of HSCT in paediatric patients requiring respiratory support

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Données en vie réelle sur l'issue de la greffe de cellules souches hématopoïétiques chez les patients pédiatriques nécessitant un soutien respiratoire

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Outcomes of pediatric patients with acute leukemias who received either post-transplant cyclophosphamide or a haploidentical transplant with TCR αβ/CD19+ lymphocyte depletion

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Franco Locatelli

Résultats des patients pédiatriques atteints de leucémies aiguës ayant reçu soit du cyclophosphamide post-transplantation, soit une greffe haplo-identique avec déplétion des lymphocytes TCR αβ/CD19+

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogénique - Haplo-identique

Principal investigator

Franco Locatelli

Mixed chimerism after related CB HSCT with hemoglobinopathies

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type of treatment

Principal investigator

Vanderson Rocha (Brazil)

Comparison of late complications after HCT using Treosulfan based and Busulfan based conditioning regimen for Hemoglobinopathy

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type of treatment

Principal investigator

Maura Faraci (Genova)

National Access and need for CAR-T CD19 therapy in Euro region

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Aleksandra Oszer(Lodz)